Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,979,784 papers from all fields of science
Search
Sign In
Create Free Account
tongxie-yaofang
Known as:
TXYF formula
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Drugs, Chinese Herbal
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Regulating effect of TongXie-YaoFang on colonic epithelial secretion via Cl- and HCO3- channel
Cheng Yang
,
Ying Xiong
,
+4 authors
Q. Zhan
World Journal of Gastroenterology
2016
Corpus ID: 5674169
AIM To investigate the pharmacological effect of TongXie-YaoFang (TXYF) formula, a Chinese herbal formula, on Diarrhea…
Expand
2015
2015
Inhibitory effect of TongXie-YaoFang formula on colonic contraction in rats.
Cheng Yang
,
Shengsheng Zhang
,
Xiao-ling Li
,
Zheng-fang Wang
,
Lu-qing Zhao
World Journal of Gastroenterology
2015
Corpus ID: 25103726
AIM To investigate the pharmacological effect of TongXie-YaoFang (TXYF) formula and its underlying mechanisms. METHODS A…
Expand
2013
2013
Kai-Xin-San, a Chinese Herbal Decoction Containing Ginseng Radix et Rhizoma, Polygalae Radix, Acori Tatarinowii Rhizoma, and Poria, Stimulates the Expression and Secretion of Neurotrophic Factors in…
K. Zhu
,
S. L. Xu
,
R. Choi
,
A. L. Yan
,
T. Dong
,
K. Tsim
Evidence-Based Complementary and Alternative…
2013
Corpus ID: 18528276
Kai-xin-san (KXS), a Chinese herbal decoction prescribed by Sun Simiao in Beiji Qianjin Yaofang about 1400 years ago, contains…
Expand
2013
2013
The effects of acupuncture therapy combined with Tongxie Yaofang on patients with diarrhea-predominant irritable bowel syndrome
Jin Jian
,
Zhao Ling-dan
2013
Corpus ID: 81910247
[目的]观察针刺联合痛泻要方治疗肠易激综合征腹泻型(D-IBS)患者的临床疗效.[方法]选择我院治疗的D-IBS患者104例,随机分为2组各52例,对照组给予西医常规治疗,观察组给予针刺联合痛泻要方治疗,观察2…
Expand
2012
2012
Treatment of diarrhea type of irritable bowel syndrome with modified Tongxie Yaofang and Shenling Baizhu Powder
Li Chun-ying
2012
Corpus ID: 76068251
Objective: To observe the clinical effects of Tongxie Yaofang and Shengling Baizhusang in the Diarrhea-type IrritableBowel…
Expand
2012
2012
Effect observation of Tongxie Yaofang and Pinaverium Bromide tablets in treatment of irritable bowel syndrome
Z. Zhi
2012
Corpus ID: 75233420
Objective To probe the effect of Tongxie Yaofang and Pinaverium Bromide tablets in treatment of irritable bowel syndrome.Methods…
Expand
2011
2011
Treatment of irritable bowel syndrome with diarrhea with combination of powder for regulating liver and spleen and Tongxie Yaofang
L. Min
2011
Corpus ID: 75711959
Objective To observe the effect of combination of powder for regulating liver and spleen and Tongxie Yaofang on irritable bowel…
Expand
2009
2009
[Tongxie Yaofang inhibits the contraction of colonic smooth muscle isolated from rats through a mechanism related to calcium mobilization].
Jian-ye Yuan
,
Jian-qun Xie
,
+4 authors
Hai-zhen Xu
Zhong xi yi jie he xue bao = Journal of Chinese…
2009
Corpus ID: 44253834
OBJECTIVE To study the relationship between the inhibitory effects of Tongxie Yaofang, a compound traditional Chinese herbal…
Expand
2008
2008
Clinical Observation of Tongxie Yaofang in Treatment of Patients with Diarrhea-type Irritable Bowel Syndrome
Huang Dun-huang
2008
Corpus ID: 75869724
Objective:To observe the clinical effects of Tongxie Yaofang in the Diarrhea-type Irritable Bowel Syndrome(IBS).Method:110 cases…
Expand
2005
2005
Effects of four regulating-intestine prescriptions on pathology and ultrastructure of colon tissue in rats with ulcerative colitis.
H. Fan
,
M. Qiu
,
Jianming Mei
,
G. Shen
,
Songbo Liu
,
Rui-Yi Chen
World Journal of Gastroenterology
2005
Corpus ID: 10128036
AIM To observe different histomorphologic changes of ulcerative colitis (UC) rats that were treated with four regulating…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE